These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4986844)
1. A management of the third stage to reduce feto-maternal transfusion. Terry MF J Obstet Gynaecol Br Commonw; 1970 Feb; 77(2):129-32. PubMed ID: 4986844 [No Abstract] [Full Text] [Related]
2. [Obstetrical management in the prevention of Rh factor immunization]. Medina Aguilar R Ginecol Obstet Mex; 1969 Mar; 25(149):257-66. PubMed ID: 4181035 [No Abstract] [Full Text] [Related]
3. Intrapartum fetomaternal bleeding in Rh-negative women. Lloyd LK; Miya F; Hebertson RM; Kochenour NK; Scott JR Obstet Gynecol; 1980 Sep; 56(3):285-8. PubMed ID: 6775254 [TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of placental cord drainage to reduce feto-maternal transfusion. Navaneethakrishnan R; Anderson A; Holding S; Atkinson C; Lindow SW Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):27-30. PubMed ID: 20018421 [TBL] [Abstract][Full Text] [Related]
6. Feto-maternal haemorrhage at therapeutic abortion. John AH; Martin R; Bothamley J J Obstet Gynaecol Br Commonw; 1970 Feb; 77(2):137-8. PubMed ID: 4986846 [No Abstract] [Full Text] [Related]
7. Management of third stage of labour, with particular reference to reduction of feto-maternal transfusion. Ladipo OA Br Med J; 1972 Mar; 1(5802):721-3. PubMed ID: 5015327 [TBL] [Abstract][Full Text] [Related]
8. Decreasing the risk of fetomaternal transfusion at the time of delivery. Hofmeister FJ; Schwartz WR; O'Leary WJ; Stanhope CR; Inman JE Am J Obstet Gynecol; 1972 Mar; 112(5):594-600. PubMed ID: 5059590 [No Abstract] [Full Text] [Related]
9. [Estimation of feto-maternal hemorrhage after delivery with a view to the prevention of anti-D immunization. Results of 5488 Kleihauer tests]. Poulain M; Huchet J Rev Fr Transfus; 1971 Jun; 14(2):219-24. PubMed ID: 5003419 [No Abstract] [Full Text] [Related]
10. Fetal-maternal macrotransfusion--a study of 400 postpartum women. Harrison KL; Baker JW Aust N Z J Obstet Gynaecol; 1978 Aug; 18(3):176-8. PubMed ID: 84666 [TBL] [Abstract][Full Text] [Related]
14. Passage of doetal cells into the maternal circulation in Rh negative women. Robinson JM; Jakobowicz R; Williams L; Moore F; Silbermann E Bibl Haematol; 1968; 29():274-9. PubMed ID: 4973599 [No Abstract] [Full Text] [Related]
15. Rh haemolytic disease. Recent advances in Rh isoimmunization prevention. Finn R Br Med J; 1970 Apr; 2(5703):219-20. PubMed ID: 4192020 [No Abstract] [Full Text] [Related]
16. The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulins. Vermylen C Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):451. PubMed ID: 5526985 [No Abstract] [Full Text] [Related]
17. Rho (D) immune prophylaxis. A double-blind cooperative study. White CA; Visscher RD; Visscher HC; Wade ME Obstet Gynecol; 1970 Sep; 36(3):341-6. PubMed ID: 4988961 [No Abstract] [Full Text] [Related]
19. The value of placental localization prior to amniocentesis. Pauls F; Boutros P Obstet Gynecol; 1970 Feb; 35(2):175-7. PubMed ID: 4984185 [No Abstract] [Full Text] [Related]
20. [Massive feto-maternal hemorrhage and prevention of Rhesus feto-maternal incompatibility]. Quartier P; Floch C; Meir F; Fruchart MF; Brossard Y; Lejeune C Arch Fr Pediatr; 1993 Feb; 50(2):175-6. PubMed ID: 8343031 [No Abstract] [Full Text] [Related] [Next] [New Search]